Defending the end zone: Studying the players involved in protecting chromosome ends

FEBS Letters

Volumn 584, Issue 17, 2010, Pages 3773-3778

  Chan, Suzanne S ^a   Chang, Sandy ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

DNA damage response; NHEJ; Shelterin; Telomere

Indexed keywords

CHROMOSOME PROTEIN; DNA; NUCLEOPROTEIN; SHELTERIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; DYSKERATOSIS CONGENITA; EUKARYOTE; GENE MUTATION; GENETIC STABILITY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TELOMERE;

ANIMALS; CELL DIVISION; CHROMOSOME FRAGILE SITES; DNA BREAKS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA-DIRECTED DNA POLYMERASE; HUMANS; MAMMALS; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TELOMERASE; TELOMERE; TELOMERE-BINDING PROTEINS;

EUKARYOTA;

EID: 77955842209     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.06.016     Document Type: Review

References (74)

1. Khanna K.K., Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 2001, 27(3):247-254.
2. Zakian V.A. The ends have arrived. Cell 2009, 139(6):1038-1040.
3. de Lange T. How telomeres solve the end-protection problem. Science 2009, 326(5955):948-952.
4. Griffith J.D., et al. Mammalian telomeres end in a large duplex loop. Cell 1999, 97(4):503-514.
5. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005, 19(18):2100-2110.
6. Broccoli D., et al. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 1997, 17(2):231-235.
7. Chen Y., et al. A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins. Science 2008, 319(5866):1092-1096.
8. Smogorzewska A., et al. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol. 2000, 20(5):1659-1668.
9. van Steensel B., de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997, 385(6618):740-743.
10. Sfeir A., et al. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 2009, 138(1):90-103.
11. Martinez P., et al. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev. 2009, 23(17):2060-2075.
12. Karlseder J., et al. Targeted deletion reveals an essential function for the telomere length regulator Trfl. Mol. Cell. Biol. 2003, 23(18):6533-6541.
13. Palm W., de Lange T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 2008, 42:301-334.
14. Bae N.S., Baumann P. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. Mol. Cell 2008, 26(3):323-334.
15. Karlseder J., et al. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999, 283(5406):1321-1325.
16. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92(3):401-413.
17. Stansel R.M., de Lange T., Griffith J.D. t-Loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang. EMBO J. 2001, 20(19):5532-5540.
18. Li B., Oestreich S., de Lange T. Identification of human Rap1: implications for telomere evolution. Cell 2000, 101(5):471-483.
19. O'Connor M.S., et al. A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proc. Natl. Acad. Sci. USA 2006, 103(32):11874-11879.
20. Takai K.K., et al. In vivo stoichiometry of shelterin components. J. Biol. Chem. 2010, 285(2):1457-1467.
21. Kaminker P.G., et al. A novel form of the telomere-associated protein TIN2 localizes to the nuclear matrix. Cell Cycle 2009, 8(6):931-939.
22. Hockemeyer D., et al. Telomere protection by mammalian Potl requires interaction with Tpp1. Nat. Struct. Mol. Biol. 2007, 14(8):754-761.
23. Kibe T., et al. Telomere protection by TPP1 is mediated by POT1a and POT1b. Mol. Cell. Biol. 2010, 30(4):1059-1066.
24. Guo X., et al. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. EMBO J. 2007, 26(22):4709-4719.
25. Xin H., et al. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 2007, 445(7127):559-562.
26. Baumann P., Cech T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 2001, 292(5519):1171-1175.
27. Loayza D., de Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003, 423(6943):1013-1018.
28. Hockemeyer D., et al. POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J. 2005, 24(14):2667-2678.
29. Wu L., et al. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 2006, 126(1):49-62.
30. Hockemeyer D., et al. Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 2006, 126(1):63-77.
31. He H., et al. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J. 2006, 25(21):5180-5190.
32. Hockemeyer D., et al. Engineered telomere degradation models dyskeratosis congenita. Genes Dev. 2008, 22(13):1773-1785.
33. Hardy C.F., Sussel L., Shore D. A RAP1-interacting protein involved in transcriptional silencing and telomere length regulation. Genes Dev. 1992, 6(5):801-814.
34. Li B., de Lange T. Rap1 affects the length and heterogeneity of human telomeres. Mol. Biol. Cell 2003, 14(12):5060-5068.
35. Sarthy J., et al. Human RAP1 inhibits non-homologous end joining at telomeres. EMBO J. 2009, 28(21):3390-3399.
36. d'Adda di Fagagna F., Teo S.H., Jackson S.P. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev. 2004, 18(15):1781-1799.
37. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 2003, 3(3):155-168.
38. Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408(6811):433-439.
39. Deng Y., Chan S.S., Chang S. Telomere dysfunction and tumour suppression: the senescence connection. Nat. Rev. Cancer 2008, 8(6):450-458.
40. Takai H., Smogorzewska A., de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 2003, 13(17):1549-1556.
41. Denchi E.L., de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007, 448(7157):1068-1071.
42. Deng Y., et al. Multiple roles for MRE11 at uncapped telomeres. Nature 2009, 460(7257):914-918.
43. Dimitrova N., de Lange T. Cell cycle-dependent role of MRN at dysfunctional telomeres: ATM signaling-dependent induction of nonhomologous end joining (NHEJ) in G1 and resection-mediated inhibition of NHEJ in G2. Mol. Cell. Biol. 2009, 29(20):5552-5563.
44. Verdun R.E., et al. Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol. Cell 2005, 20(4):551-561.
45. Karlseder J., et al. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol. 2004, 2(8):E240.
46. Zou L., Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 2003, 300(5625):1542-1548.
47. Maser R.S., DePinho R.A. Connecting chromosomes, crisis, and cancer. Science 2002, 297(5581):565-569.
48. Hartlerode A.J., Scully R. Mechanisms of double-strand break repair in somatic mammalian cells. Biochem. J. 2009, 423(2):157-168.
49. Celli G.B., de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell. Biol. 2005, 7(7):712-718.
50. Celli G.B., Denchi E.L., de Lange T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell. Biol. 2006, 8(8):885-890.
51. Dimitrova N., et al. 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature 2008, 456(7221):524-528.
52. D'Amours D., Jackson S.P. The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat. Rev. Mol. Cell. Biol. 2002, 3(5):317-327.
53. Buis J., et al. Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation. Cell 2008, 135(1):85-96.
54. Zhu X.D., et al. ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol. Cell 2003, 12(6):1489-1498.
55. Bailey S.M., et al. Strand-specific postreplicative processing of mammalian telomeres. Science 2001, 293(5539):2462-2465.
56. Espejel S., et al. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 2002, 21:2207-2219.
57. Maser R.S., et al. DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse. Mol. Cell. Biol. 2007, 27(6):2253-2265.
58. Nikitina T., Woodcock C.L. Closed chromatin loops at the ends of chromosomes. J. Cell Biol. 2004, 166(2):161-165.
59. He H., et al. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicitphenotypes resembling dyskeratosis congenita. Mol. Cell. Biol. 2009, 29(1):229-240.
60. Chai W., et al. The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G-overhangs at human telomeres. EMBO Rep. 2006, 7(2):225-230.
61. Attwooll C.L., Akpinar M., Petrini J.H. The mre11 complex and the response to dysfunctional telomeres. Mol. Cell. Biol. 2009, 29(20):5540-5551.
62. van Overbeek M., de Lange T. Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase. Curr. Biol. 2006, 16(13):1295-1302.
63. Lenain C., et al. The Apollo 5' exonuclease functions together with TRF2 to protect telomeres from DNA repair. Curr. Biol. 2006, 16(13):1303-1310.
64. Lam, Y.C. et al. (in press) SNMIB/Apollo protects leading-strand telomeres against NHEJ-mediated repair. EMBO J., in press.
65. Lee H.W., et al. Essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392(6676):569-574.
66. Savage, et al. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am. J. Hum. Genet. 2008, 82:501-509.
67. Keegan C.E., et al. Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator. Hum. Mol. Genet. 2005, 14(1):113-123.
68. Else T., et al. Tpp1/Acd maintains genomic stability through a complex role in telomere protection. Chromosome Res. 2007, 15(8):1001-1013.
69. Else T., et al. Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell 2009, 15(6):465-476.
70. Vlangos C.N., et al. Caudal regression in adrenocortical dysplasia (acd) mice is caused by telomere dysfunction with subsequent p53-dependent apoptosis. Dev. Biol. 2009, 334(2):418-428.
71. Artandi S.E., et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406(6796):641-645.
72. Lazzerini Denchi E., Celli G., de Lange T. Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication. Genes Dev. 2006, 20(19):2648-2653.
73. Munoz P., et al. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer. Nat. Genet. 2005, 37(10):1063-1071.
74. Blanco R., et al. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. Genes Dev. 2007, 21(2):206-220.